School of Medicine
Showing 41-60 of 215 Results
-
Paul Graham Fisher, MD
Beirne Family Professor of Pediatric Neuro-Oncology, Professor of Pediatrics and, by courtesy, of Neurosurgery and of Epidemiology and Population Health
Current Research and Scholarly InterestsClinical neuro-oncology: My research explores the epidemiology, natural history, and disease patterns of brain tumors and other cancers in childhood, as well as prospective clinical trials for treating these neoplasms. Research interests also include neurologic effects of cancer and its therapies.
-
Rebecca M. Gardner
Ph.D. Student in Epidemiology and Clinical Research, admitted Autumn 2022
BioMy research interests are in maternal nutrition and well-being, with a current focus on hyperemesis gravidarum (HG)—severe nausea and vomiting during pregnancy that often causes significant maternal undernutrition and poor antepartum and postpartum mental health, and is the leading cause of hospitalization in early pregnancy. I study HG from several angles: the environmental exposures that may exacerbate it, including ambient air pollution and wildfire smoke, and whether these contribute to HG-related hospitalization; and its downstream consequences for both mothers and children, including hypertensive disorders of pregnancy such as preeclampsia, preterm birth, and neurodevelopmental conditions in childhood such as autism. More broadly, I am interested in hypertensive disorders of pregnancy, preterm birth, and gestational diabetes, and their subsequent effects on offspring. Methodologically, I am drawn to applying causal inference methods traditionally used in economics to questions in public health.
Before starting a PhD, I was a biostatistician in the Quantitative Sciences Unit at Stanford for four years where I co-authored over thirty publications, collaborating with clinicians on various domains including developmental behavioral pediatrics, reproductive endocrinology & infertility, oncology, and clinical trials. I completed my MS in Statistics at Brigham Young University in 2016, where I collaborated with cardiologists to develop a new approach to diagnose rheumatic heart disease in pediatric patients in Samoa for my Master's thesis. -
Pascal Geldsetzer
Assistant Professor of Medicine (Primary Care and Population Health) and, by courtesy, of Epidemiology and Population Health
BioPascal Geldsetzer is an Assistant Professor of Medicine in the Division of Primary Care and Population Health and, by courtesy, in the Department of Epidemiology and Population Health. He is also affiliated with the Phil & Penny Knight Initiative for Brain Resilience at the Wu Tsai Neurosciences Institute, Department of Biomedical Data Science, Department of Health Policy, and the Stanford Center for Population Health Sciences.
His research focuses on identifying and evaluating the most effective interventions for improving health at older ages. In addition to leading several randomized trials, his methodological emphasis lies in the use of natural experiments to ascertain causal effects in large observational datasets, particularly in electronic health record data. He has won an NIH New Innovator Award (in 2022), a Chan Zuckerberg Biohub investigatorship (in 2022), and three NIH R01 grants as Principal Investigator (in 2023 and 2024). In 2026, he was named one of the 100 most influential people in health and medicine globally by TIME Magazine. -
Nicole Gladish
Research Fellow, Epidemiology and Population Health
BioDr. Nicole Gladish is a Research Fellow in the Department of Epidemiology and Population Health at Stanford University. Her work integrates genetic, epigenetic, and population-level data to understand how biological and environmental factors interact to shape health disparities and influence trajectories of healthy aging. In addition to exploring molecular mechanisms, she conducts applied research on health policy interventions developing and refining tools like deprivation indices to inform equitable decision-making at the systems level.
Dr. Gladish earned her Ph.D. in Medical Genetics from the University of British Columbia (UBC), where her thesis focused on how early-life adversity, such as low socioeconomic status and abuse, affects DNA methylation patterns. This work aimed to elucidate the biological mechanisms that predispose individuals to chronic diseases such as cardiovascular disease, diabetes, and cancer.
At Stanford, she continues to investigate the interplay between social determinants and biological risk, with a growing emphasis on translational research. Her development of improved social deprivation indices supports more accurate identification of disadvantaged communities, informing public health funding, service allocation, and structural interventions across the U.S.
Dr. Gladish's work bridges molecular epidemiology and public policy, aiming to ensure that scientific insights translate into measurable improvements in population health. -
Steven Goodman
Professor of Epidemiology and Population Health, of Medicine (Primary Care and Population Health) and, by courtesy, of Health Policy
Current Research and Scholarly InterestsI study issues relating to the representation and measurement of evidence in medical research and determinants of the reliability of biomedical research findings. I also do work in evidence synthesis, comparative effectiveness research, and the ethics of clinical research.
-
Britni Wilcher
Affiliate, Center for Population Health Sciences
BioBritni Wilcher, PhD, is a Visiting Scholar in the Department of Health Policy at Stanford University and an applied microeconomist working at the intersection of health, labor, and gender economics. Dr. Wilcher's research focuses on the economics of health decision making and its implications for labor markets using quasi-experimental designs. Her research portfolio spans vulnerable populations and policy interventions, from evaluating teletherapy adoption patterns among 200,000+ veterans to conducting regulatory impact analyses protecting 22+ million workers nationwide. Her collaborative research products have withstood judicial review up to the Supreme Court and provided evidence-based input into policy actions. Her work has been cited in congressional testimony and the 2022 Economic Report of the President. It has been featured in federal regulations and published in peer-reviewed journals including Labour Economics, Health Economics, Value in Health, and the International Journal of Technology Assessment in Health Care.
Dr. Wilcher has worked in management consulting, government, universities, and has consulted with think tanks, foundations, the EU Commission, and a United Nations entity. She holds a PhD in Economics from American University, an MSc in International Health Care Management, Economics, and Policy from SDA Bocconi School of Management, and a BA in Economics from Spelman College. -
Bonnie Halpern-Felsher
Marron and Mary Elizabeth Kendrick Professor of Pediatrics and Professor, by courtesy, of Epidemiology and Population Health and of Psychiatry and Behavioral Sciences (Child and Adolescent Psychiatry)
Current Research and Scholarly InterestsResearch focuses on developmental, cognitive and psychosocial factors involved in adolescents’ and young adults’ health-related decision-making, perceptions of risk and vulnerability, health communication and risk behavior. My research has focused on understanding and reducing health risk behaviors such as tobacco use, alcohol and marijuana use, risky driving, and risky sexual behavior.
-
Summer Han
Associate Professor (Research) of Neurosurgery, of Medicine (Computational Medicine) and, by courtesy, of Epidemiology and Population Health
Current Research and Scholarly InterestsMy current research focuses on understanding the genetic and environmental etiology of complex disease and developing and evaluating efficient screening strategies based on etiological understanding. The areas of my research interests include statistical genetics, molecular epidemiology, cancer screening, health policy modeling, and risk prediction modeling. I have developed various statistical methods to analyze high-dimensional data to identify genetic and environmental risk factors and their interactions for complex disease.
